Literature DB >> 10064222

Kawasaki syndrome.

W H Mason1, M Takahashi.   

Abstract

KS is a fascinating illness of childhood that has emerged over the last 30 years and is now recognized as the most common cause of acquired heart disease in children in the United States. It has a dramatic clinical presentation in most cases, but for a small number of cases that present with a more subtle disease there appears to be a greater risk of coronary artery complications. Progress has been made in the management of KS, but although the disease appears to be related to an infectious etiology, no infectious agent has been proven to be the cause. Finally, issues in long-term management and prognosis are yet to be clarified.

Entities:  

Mesh:

Year:  1999        PMID: 10064222     DOI: 10.1086/515133

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Recognition and management of Kawasaki disease.

Authors:  R K Han; B Sinclair; A Newman; E D Silverman; G W Taylor; P Walsh; B W McCrindle
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

Review 2.  Congenital heart disease: current indications for antithrombotic therapy in pediatric patients.

Authors:  M D Reller
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

3.  Challenges in early diagnosis of Kawasaki disease in the pediatric emergency department: differentiation from adenoviral and invasive pneumococcal disease.

Authors:  Lorna Stemberger Maric; Neven Papic; Mario Sestan; Ivica Knezovic; Goran Tesovic
Journal:  Wien Klin Wochenschr       Date:  2018-02-23       Impact factor: 1.704

Review 4.  Salicylate for the treatment of Kawasaki disease in children.

Authors:  J H Baumer; S J L Love; A Gupta; L C Haines; I Maconochie; J S Dua
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 5.  Kawasaki disease: an update.

Authors:  Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.686

Review 6.  Mercury promotes catecholamines which potentiate mercurial autoimmunity and vasodilation: implications for inositol 1,4,5-triphosphate 3-kinase C susceptibility in kawasaki syndrome.

Authors:  Deniz Yeter; Richard Deth; Ho-Chang Kuo
Journal:  Korean Circ J       Date:  2013-09       Impact factor: 3.243

7.  Ethnic Kawasaki Disease Risk Associated with Blood Mercury and Cadmium in U.S. Children.

Authors:  Deniz Yeter; Michael A Portman; Michael Aschner; Marcelo Farina; Wen-Ching Chan; Kai-Sheng Hsieh; Ho-Chang Kuo
Journal:  Int J Environ Res Public Health       Date:  2016-01-05       Impact factor: 3.390

Review 8.  Kawasaki disease: 40 years after the original report.

Authors:  Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.